No Prescription |
 |
 | ||
|
Clindatech Top Soln Cleocin T |
|
| ||
No Prescription » Prescription Drugs 4 » Clindatech Top Soln Cleocin T This medication is used to treat acne. It helps to decrease the number of acne lesions. Clindamycin is an antibiotic which works by stopping the growth of bacteria.Indication:ClindaTech Topical Solution is indicated for the topical treatment of acne vulgaris particularly forms in which comedones papules and pustules predominate.DOSAGE AND ADMINISTRATION:ClindaTech Solution is for external use only and is applied directly on the skin. Wash the entire face with mild non-alkaline soap and warm water prior to any application. Using the Dab-O-Matic applicator provided apply a thin film directly to each acne lesion or to areas having potential of eruption. ClindaTech Solution is usually applied to affected areas twice daily once every morning and once at bedtime. The frequency of treatment will depend on the severity of acne condition as well as skin tolerance but should not be more than twice daily. Advice for monitoringTreatment of acne vulgaris needs to be individualised according to the type of lesion predominate and the response of therapy. Application to the entire face of an average adult is equivalent to approximately 2ml of solution or clindamycin 20mg.Generally a decrease in the number of inflammatory lesions should be noticed after two or six weeks but more than eight weeks of therapy may be required before any definite beneficial effects are observed. Therapy is usually continued until a satisfactory response is obtained. If condition does not seem to improve or worsens modification of treatment or alternative therapy should be considered. Buy Clindatech Top Soln Cleocin T and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Clindatech Top Soln Cleocin T: Product Type: Prescription Drugs 4 Clindatech Top Soln ( Cleocin T Clinda-Derm Generic Clindamycin ) Clindatech Top Soln (Cleocin T Clinda-Derm Generic Clindamycin) Cleocin T Clinda-Derm Generic Clindamycin 1%w/v 100mL(2 x 50mL) 50mL Cleocin T Clinda-Derm Generic Clindamycin Clindatech Top Soln
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
